New combo therapy aims to cut stroke risk in half

NCT ID NCT06591338

First seen Oct 31, 2025 · Last updated Apr 30, 2026 · Updated 23 times

Summary

This study compares two antiplatelet drug combinations—aspirin plus ticagrelor versus aspirin plus clopidogrel—in 900 adults who recently had a minor stroke or transient ischemic attack (TIA) caused by large-artery disease. Participants receive treatment within 24 hours of their first event and are followed for three months to see which combination better prevents new strokes while minimizing bleeding side effects. The goal is to find a safer, more effective way to manage stroke risk.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kafr Elsheikh University Hospital

    RECRUITING

    Kafr ash Shaykh, 33511, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.